BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03439280-completion@plaintrial.com
DTSTAMP:20261027T202052Z
DTSTART;VALUE=DATE:20220128
SUMMARY:A Study to Investigate the Safety\, Tolerability\, Efficacy\, Pharm
 acokinetics\, and Immunogenicity of TAK-079 Administered Subcutaneously as
  a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple My
 eloma (MM) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03439280
URL:https://plaintrial.com/trial/NCT03439280
END:VEVENT
END:VCALENDAR